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CompartmentationThe heart must constantly adapt its activity to the needs of the body. In any potentially dangerous or physi-
cally demanding situation the activated sympathetic nervous system leads a very fast cardiac response.
Under these circumstances, α1-adrenergic receptors activate intracellular signaling pathways that ﬁnally
phosphorylate the caveolae-located subpopulation of Kv4 channels and reduce the transient outward K+ cur-
rent (Ito) amplitude. This reduction changes the shape of the cardiac action potential and makes the plateau
phase to start at higher voltages. This means that there are more calcium ions entering the myocyte and the
result is an increase in the strength of the contraction. However, an excessive reduction of Ito could danger-
ously prolong action potential duration and this could cause arrhythmias when the heart rate is high. This ex-
cessive current reduction does not occur because there is a second population of Ito channels located in
non-caveolar membrane rafts that are not accessible for α1-AR mediated regulation. Thus, the location of
the components of a given transduction signaling pathway in membrane domains determines the correct
and safe behavior of the heart. This article is part of a Special Issue entitled: Reciprocal inﬂuences between
cell cytoskeleton and membrane channels, receptors and transporters. This article is part of a Special Issue en-
titled: Reciprocal inﬂuences between cell cytoskeleton and membrane channels, receptors and transporters.
Guest Editor: Jean Claude Hervé.
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Fig. 1. Ito current recording from a ventricular cardiomyocyte. The cell was maintained
at a holding potential of−60 mV and depolarized during 500 ms to +50 mV. The cur-
rent activates very fast, in few milliseconds, and inactivates rapidly. Noradrenaline
(NA) reduces the current amplitude in a concentration dependent manner.
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When working, exercising or simply sleeping, the heart must
adapt its activity in order to fulﬁll the needs of the body. The sympa-
thetic nervous system plays a key role in regulating the heart rate and
the ventricular contraction force. The sympathetic neurotransmitter
norepinephrine activates intracellular signaling pathways that affect
the cardiac ionic channels and thereby changes the electrical behavior
of the heart. However, as some components of the transduction
systems can be preassembled, the signaling mechanism depends on
the integrity of the cytoskeleton. Moreover, it also depends on the
precise location of the channels within the cell membrane. Thus, for
Kv4 channels activation of α1-adrenoceptors only regulates the
caveolae located population.
In this reviewwewill describe some of the effects of sympathetic in-
nervation on the electrical activity of the heart, which are determined
by changes in the electrical activity of every single cardiac cell, which
in turn are due to changes in the behavior of each individual ionic chan-
nel. Wewill focus on the regulation of the transient outward potassium
current, Ito, by norepinephrine discussing how cytoskeleton-mediated
compartmentalization provides signal speciﬁcity.
1.1. Adrenergic regulation of cardiac ionic channels
In cardiac myocytes, the action potential is divided in phases 0 to
4. The inward Na+ current (INa) is responsible for the rapid upstroke
or phase 0 of the action potential. The transient outward potassium
current, Ito, is responsible for the initial rapid repolarization or
phase 1. The inward L-type calcium current (ICa-L), counterbalanced
by the rapid and slow delayed rectiﬁers IKr and IKs are responsible
for the plateau or phase 2. The rapid ﬁnal repolarization or phase 3
is due to the closing of Ca2+ channels and the increase in K+ currents.
Finally, the inward rectiﬁer IK1 is responsible for the maintenance of
the resting membrane potential or phase 4.
The sympathetic innervation of the heart affects the shape and
duration of the cardiac action potential as it regulates the ionic currents
involved in the repolarization. Thus, norepinephrine reduces the ampli-
tude of the transient outward potassium current through α1-
adrenoceptors (α1-AR) [1] and therefore reduces the phase 1 of the
cardiac action potential. As a consequence, there is a larger calcium inﬂux
into the cell during the subsequent plateau that increases the force of the
contraction [2]. On the other hand, stimulation of β-adrenoceptors
(β-AR) is necessary to maintain Ito current at physiological levels [1].
The sympathetic nervous system also regulates the Phase 2 of the
cardiac action potential, affecting the ﬂow of both potassium and cal-
cium ions. In fact, perhaps the best known effect of β-AR stimulation
in the heart is the activation of the cascade of Gαs protein and
adenylyl cyclase that leads to the phosphorylation of the Cav1.2
channel by protein kinase A (PKA), which increases the inward L-type
calcium current and therefore the force of contraction [3]. The A kinase
Anchoring Proteins or AKAPsmight help these components to differently
associate in separated membrane microdomains of the cardiomyocyte
[4]. The increase in the magnitude of ICa-L would prolong the duration
of phase 2. However, this effect is counterbalanced by the effect on K+
currents.
Regarding the slow delayed rectiﬁer IKs, formed by the Kv7.1
channel together with the accessory protein KCNE1 or mink [5,6], the
sympathetic innervation increases current amplitude and therefore
shortens the repolarization. Again, this effect is caused by the stimula-
tion of β-AR, Gαs protein, adenylyl cyclase and the phosphorylation of
the channel by PKA. In this intracellular pathway receptor, channel,
PKA and protein phosphatase 1, that is the phosphatase that reverts
the phosphorylation, are associated to form a supramolecular complex
brought together through the anchoring protein Yotiao [7,8].
Last, the sympathetic regulation of the rapid delayed rectiﬁer IKr,
driven by the HERG channel, is more elusive. In heterologousexpression systems norepinephrine causes opposite effects depending
on the concentration and receptor type. Initially, stimulation of β-AR
triggers the phosphorylation of HERG channel by PKA, which together
with cAMP direct interaction with an intracellular CNBD (Cyclic Nucle-
otide Binding Domain) of the channel reduces the amplitude of the IKr
current. However, the subsequent binding of the phosphorylated chan-
nel to the 14-3-3 protein increases current amplitude [9–11]. Similarly,
the regulation of the channel uponα1-AR stimulation is also confusing.
Apparently, stimulation of theα1-adrenergic receptormight inhibit the
channel by a mechanism involving channel phosphorylation. However,
the deletion of most of the phosphorylation consensus sites for Ser/Thr
protein kinases does not reduce the effect on the channel [12].
In the global picture, both inward Ca2+ and outward K+ currents
are increased after sympathetic innervation but the effect on K+
repolarizing currents is stronger. That means that in the sympathetic
stimulated heart the repolarization is faster and the action potential
duration is shorter. This is required for the heart to beat at a higher
frequency.2. The transient outward K+ current, Ito
2.1. Molecular correlates of the transient outward K+ current, Ito
The transient outward is a fast activating and rapidly inactivating
potassium current (Fig. 1), responsible for the phase 1 of the cardiac
action potential, the initial rapid repolarization from the peak of the
action potential until the plateau level [13].
There are at least two different phenotypes of Ito in the mammali-
an hearts that differ in the velocity of recovery from inactivation. Ito
fast (Ito,f) has a recovery of inactivation rate of 70 ms approximately,
whereas Ito slow (Ito,s) recovers in 1 s. These two phenotypes indicate
that there are at least two types of Ito channel forming proteins or “α
subunits”. Several genes of the Kv (Voltage-dependent K+ Channels)
family encode Ito channels: KCNA4, KCND2 and KCND3 genes [14–17].
KCNA4 gene encodes the Kv1.4 channel responsible for the Ito,s with
the characteristic slow recovery rate that is found in rabbit ventricle
[18] and human endocardium [19]. However, Ito,f is the predominant
phenotype [20] and is currently accepted that KCND2 and KCND3
genes encode the Kv4.2 and Kv4.3 proteins, responsible for the Ito,f
channels in rat cardiomyocytes [16,21,17].
In rat ventricle, the transient outward K+ current is generated
through two different channels: a homotetramer formed by Kv4.3
channels in endocardium and a mixture of Kv4.2 and Kv4.3 channels
in epicardium. In humans, Ito is mainly driven by Kv4.3 channels be-
cause that is the only isoform expressed in enough amounts [17].
Like in other species, in human ventricle the Ito current gradient be-
tween endocardium and epicardium is observed. Since the expression
of Kv4.3 channel is homogeneous throughout the ventricle, the
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regulatory subunit KChlP2 [22].
2.2. Adrenergic regulation of the transient outward K+ current, Ito
Norepinephrine has different effects on Ito current. Thus, the basal
β-AR stimulation has a trophic effect that ensures Ito expression at
physiological levels, whereas the acute α1-adrenergic receptors
(α1-AR) stimulation decreases the current amplitude [1].
2.2.1. β2-adrenoceptor mediated trophic effect on Ito
β-adrenoceptors are major regulators of cardiac physiology as
they mediate catecholamine-induced inotropic, chronotropic and
lusitropic responses. Therefore, β-ARs transduction pathways have
been extensively studied.
Although they differ in physiological roles and pharmacological
properties, both β1 and β2-ARs activate the classic Gαs-AC-cAMP-PKA
pathway, whereas only β2 activate also Gαi protein [23,24]. Our
group has found that this dual coupling of β-ARs to Gαs and Gαi
proteins described in cultured cells [23,25–27] is in fact active in rat
isolated adult cardiomyocytes [28]. Thus, in cardiac myocytes β2-AR
stimulation activates the Gαs protein, adenylyl cyclase and PKA. The
PKA-phosphorylated receptor then switches to a Gαi protein whose
βγ complex activates β-ARK1. Once dually phosphorylated by PKA
and β-ARK1, the β2-AR internalizes in a process that requires Arrestin
[26,27]. The internalized β2-Adrenoceptor-Arrestin complex recruits
cSrc and activates Ras, which thereby activates MEK1/2 and ﬁnally
ERK1/2.We recently found a physiological function for this intracellular
pathway [28], where theMAPK cascade modulates the Kv4.2 and Kv4.3
protein levels in the cellmembrane, and therefore Ito current amplitude,
in response to tonic β-adrenergic stimulation (Fig. 2).
It is noteworthy that the increase in Ito current amplitude induced
by the activation of the MAP kinase cascade is due to an increased
channel protein synthesis [29], and this effect depends on the integri-
ty of the cytoskeleton, probably in order to allow the translocation of
newly formed channels to the plasma membrane [30].
2.2.2. α1-adrenoceptor mediated reduction on Ito current
Several studies have reported that acute noradrenergic stimulation
reduces the transient outward potassium current amplitude in different












Fig. 2. Intracellular pathway connecting the β-Adrenoceptor activationwith the Ito channel
expression through the activation of theMAPkinase cascade by the internalized receptor. In
cardiac myocytes β2-AR sustained stimulation results in receptor desensitization and inter-
nalization in a process that requires Arrestin. The β2-Adrenoceptor-Arrestin complex
recruits cSrc and activates Ras, which thereby activates MEK1/2 and ERK1/2. Finally, the
MAPK cascade modulates the Kv4.2 and Kv4.3 protein levels in the cell membrane, and
therefore Ito current amplitude, in response to sympathetic stimulation.sinceα1-adrenergic blocker prazosin, but not theβ-blocker propranolol
completely prevents the effect [31,32].
α1-adrenergic receptors classically couple to the Gαq protein-PLC
pathway. However, in heterologous expression systems they can alter-
natively couple toGαs proteins [33,34].Moreover, in rat cardiomyocytes,
the mechanism responsible for the α1-adrenoceptor induced Ito reduc-
tion requires the activation of Gαs protein. This coupling activates the
cAMP/PKA pathway, which ﬁnally phosphorylates the Ito channel
(Fig. 3) and reduces the amplitude of the transient outward potassium
current up to a 35% [32,35].
The reduction of the amplitude of the Ito current induced by
noradrenaline is concentration dependent and saturates with 30 μM
norepinephrine [32]. This result is surprising and arises some questions
like why does noradrenaline reduce Ito current only a third; why do not
higher noradrenaline concentrations fully abolish Ito current; or how
does α1-AR stimulation activate PKA without affecting i.e. L-type
calcium channels. In addition, if cAMP/PKA intracellular pathway
phosphorylates the Ito channel, why does β-adrenoceptors stimulation
have no effect on Ito? These questions will be discussed below.
3. Compartmentalization mechanisms
Traditionally, the interaction Receptor-G Protein-Efector was
believed to be based on random collision of its components in the
Fluid Mosaic of the membrane. But this model does not ﬁt with
what today is known as the non-randomness of the membranes. A
clear example of that is the regulation of Ito current by adrenergic
receptors [35].
α1- and β-adrenergic receptors activate the cAMP/PKA intracellular
pathway, but only α1-adrenoceptor activation phosphorylates the Ito
channel. This pathway requires a large number of proteins interacting
together in milliseconds. One of the proteins involved is adenylate cy-
clase, which accounts for 0.001% of the membrane proteins, making
its random collision with other involved molecules unlikely in the
milliseconds frame. It is therefore necessary the preassembly of the
components of the signaling as this would accelerate the response at
the same time that separates responses carried by same effectors, but
triggered by various agonists [36,37]. Some of themechanisms involved
in the compartmentalization of these signals include AKAPs and
membrane rafts [38,39].
3.1. AKAPs
In cardiac muscle cells, the cAMP-dependent PKA has multiple sub-
strates like L-type Ca2+ channels in the sarcolemma [40,41], ryanodine
receptors, phospholamban and Cl− channels in the sarcoplasmic reticu-
lum [42,43] and troponin I in the thickﬁlaments [42]. The need for com-
partmentalization of PKA in the heart was proposedmore than 30 years
ago [36,37]. It is currently known that a way of orchestrating cAMP
signaling is to maintain local populations of PKA in an inactive form
through its association with A-kinase-anchoring proteins. These pro-
teins bind to PKA and direct the enzyme to speciﬁc targets by binding
also to the cytoskeleton, membranes or organelles [44]. In fact, AKAPs
formmultifunctional complexes in away thatmight ensure the proxim-
ity of the various components of a signal transmission system.
Moreover, AKAPs may integrate different signaling pathways thereby
allowing the reversibility of the signal, for instance, directing the phos-
phorylation and then the desphosphorylation of a given substrate [45].
Thus, compartmentalization of PKA by AKAP is an important mecha-
nism of regulation of adrenergic signaling in the heart.
3.2. Membrane rafts and caveolae
On the other hand, there are membrane microdomains, the
membrane rafts, where different receptors co-localize with compo-









Fig. 3. Intracellular pathway connecting the α1-Adrenoceptor activation with the Ito channel phosphorylation and subsequent reduction of current amplitude. Activated α1-AR
couples to a Gαs protein and activates the cAMP/PKA signaling cascade, which leads to Kv4 channels phosphorylation and reduction of Ito.
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regulation of ionic channels [46]. Basically, membrane rafts are rich in
cholesterol and sphingolipids, which give them a stiffer consistency
than the rest of the membrane [47]. However, based on its structure
and the presence of speciﬁc markers there are different types of
rafts and, among them, caveolae are the best studied.
Unlike other membrane rafts, caveolae form invaginations in the
plasma membrane of approximately 50–100 nm size (Fig. 4). They
are especially abundant in the cells of the cardiovascular system
including endothelial and smooth muscle cells, cardiac myocytes
and ﬁbroblasts [48]. The hallmark of caveolar microdomains is the
presence of caveolin [49], the protein responsible for the characteris-
tic invaginated morphology.
Caveolae concentrates a wide variety of molecules involved in cell
signaling, such as G protein coupled receptor, protein kinases, ionic
channels [50] and even the endothelial nitric oxide synthase, an en-
zyme that is not found in other areas of the plasma membrane [51].
Some of these proteins are bound to caveolin through the caveolin
scaffolding domain (CSD). This binding is important because keeps
the enzyme in an inactive state until the right activator appears and
releases the inhibition [52,53]. Caveolin-3 is the isoform expressed
in cardiac myocytes and in skeletal muscle ﬁbers [54,55] and different
studies have demonstrated that both the deﬁcit of caveolin-3 as its
overexpression triggers cardiac pathologies [56–58].
One of the ﬁrst molecules identiﬁed in caveolae was the α subunit
of the G protein [52], A distribution analysis of G protein subunits in
cardiomyocytes shows that whereas proteins Gαi/0 and Gαq are
highly concentrated in caveolar regions, Gαs proteins and βγ subunit
locate equally in and out caveolae [59,60]. Similarly, adenylyl cyclase
and PKA are also found in caveolae in cardiomyocytes [59,61–63]. As
mentioned above, when in caveolae G proteins, adenylyl cyclase or
PKA display an inactive conformation due to its interaction withFig. 4. Caveolae (white arrowheads) in the membrane of cardiac myocytes. Membrane raf
proteins involved in cellular signaling, including receptors, protein kinases and phosphsta
due to the presence of the protein caveolin.caveolin. [59,62–64]. Thus, the particular localization of these en-
zymes provides a mechanism to inhibit their activity in the absence
of activators. In addition, palmitoylation processes can help the
location of some proteins in membrane rafts and coating of this
palmitoylation can help the movement of molecules in and out of
the membrane rafts in response to stimulation by agonists [55,65,66].
4. Intracellular transduction components and ionic channels
locate in membrane rafts
4.1. Ionic channels in membrane rafts
Ionic channels do not locate randomly along the cell membrane,
but rather follow a particular distribution that allows for the correct
electrical behavior of the cell. For instance, in cardiac myocytes
Kv1.5 channels concentrate in regions of cell-to-cell contact [67].
Moreover, brain ion channels not only show different distribution
between axon and dendrites, but also along the dendrites [68].
Most of ionic channels, such as: Kv1.4, Kv1.5, Kv2.1, Kv4, or Cav
are located on membrane rafts [69,70,59,71,72] sometimes in a tissue
speciﬁc manner. Thus, the voltage dependent potassium channels
Kv1.5 and Kv4.3 locate in caveolae in mouse L cells and in
cardiomyocytes respectively, whereas Kv2.1 channels are found in
non caveolar membrane rafts of L cells and neurons [70–72]. The
location in rafts facilitates the interaction with different proteins,
and directly modulates the activity of these channels. In this sense,
the rupture of membrane rafts alters the biophysical behavior of
Kv1.5, Kv2.1 or Kv11.1 channels in different cell types [70,71,73].
In some cases, posttranslational modiﬁcations such as palmitoylation
and myristoylation [74], the fractions of glycosyl phosphatidyl inositol
known as “GPI anchors” [75] or transmembrane domains residues [76]
favor its localization in membrane rafts. In other cases, the channels arets are microdomains enriched in sphingolipids and cholesterol which can concentrate
ses and ionic channels. Caveolae are membrane rafts with a characteristic ﬂask shape
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ed to their ﬁnal localization by the interaction with other proteins such
as other ionic channels or MAGUK proteins [77–79].4.2. There are two distinct populations of Ito channels, one caveolin-
associated and another one caveolin-independent
Regarding the localization of Ito channel forming proteins Kv4.2
and Kv4.3, both membrane fractionation and coimmunoprecipitation
experiments showed that they localize in membrane rafts in rat
cardiomyocytes. When membrane microdomains are isolated by cen-
trifugation in density gradients, Kv4 channels are found in low densi-
ty fractions or membrane rafts and, as expected, raft disruption with
cholesterol extracting agents displaces Kv4 channels to high density
fractions [72].
However, this method does not distinguish whether or not these
membrane rafts are caveolae. Since cytoskeleton disruption leads to
caveolae internalization, disrupting agents such as colchicine or cyto-
chalasin are typically used to discriminate between caveolar and
non-caveolar membrane rafts [80–82]. When the isolation of mem-
brane microdomains in density gradients is performed in the presence
of colchicine, only half of the Kv4 channels migrate to high density
fractions, suggesting the existence of two different channel populations,
one in caveolae and another one in planar membrane rafts.
Coimmunoprecipitation experiments between caveolin and Kv4 chan-
nels, as well as electron microscopy immunostaining [72] conﬁrmed
the existence of a caveolin-associated and a caveolin-independent
population of Kv4 channels (Fig. 5).
In rat ventricular cardiomyocytes, heterotetramers of Kv4.2 and
Kv4.3 proteins form the channel responsible for the Ito current [83].
However, this raises an important issue in relation to the expression
of these channels in caveolae, as Kv4.3 channels are localized in mem-
brane rafts in cardiac myocytes [72], but the localization of Kv4.2 is
controversial. Thus, whereas Kv4.2 channels are not found in any
type of membrane rafts in mouse L cells or hyppocampal neurons
[69], they locate in caveolae of TS201 cells, cardiac myocytes and sur-
prisingly hyppocampal neurons [84,72]. Furthermore, the association
of Kv1.4 channel with PSD95 protein, which also associates to the
channel Kv4.2, translocates these channels to caveolae [71,84]. This
could mean that the Kv4.2 channel is unable to locate in rafts by itself,
but can be transferred to rafts by the proteins it associates with. In
this sense, is interesting to point out that the Kv.3 protein has a
consensus sequence for caveolin binding (ΦxxxxΦxxΦ, aminoacids
165–173) and Kv4.2 does not. Thus, the Kv4.3 could be the scaffolding
protein that locates the Kv4.2 channel in membrane rafts in cardiac
myocytes.Kv4 
Membrane Raft
Fig. 5. All Kv4 channels are located in membrane rafts in cardiac myocytes. However, two
other is located in planar membrane rafts, leading to the existence of two different populat
Only the caveolae located population of Kv4 channels can be regulated by α1-AR stimulatio
the caveolae-located effectors of α1-ARs.4.3. Adrenergic receptor location in membrane rafts
Although PKA is a broad-speciﬁc kinase activated by cAMP and a
number of agonists increase cAMP and activate PKA, they have very
different cellular effects [85,86]. This suggests that the α1-AR/PKA/
Ito pathway can be compartmentalized and limited to speciﬁc mem-
brane regions. In fact, the cAMP increase and the PKA dependent
phosphorylation of the Ito channels after α1-AR stimulation only
occur when both the sarcoplasmic membrane and the cytoskeleton
integrity are maintained [35].
In this sense, caveolae can host complexes formed by G protein
coupled receptors, heterotrimeric G proteins, regulators and effectors.
A large number of GPCRs can localize in membrane rafts and in some
cases a pre-assembly of signaling complexes with the receptor
already exists in membrane rafts. In other cases, the interaction of
the agonist with the receptor makes G protein migrate to membrane
rafts and take part in receptor desensitization and internalization
processes [87,88].
Raft isolation by sucrose density gradients and immunoprecipitation
experiments demonstrate that the α1-adrenergic receptor and Gαq
protein are located physically together in caveolae [60]. Similar results
have been obtained for the components of the β-AR signaling-Gαs
protein pathway, which are also localized in membrane rafts and in
caveolae in rat ventricular myocytes and in heterologous expression
systems [59].
One work demonstrated that when the α1-adrenergic receptor is
stimulated in isolated membranes of cardiac myocytes cAMP is not
increased. However, when the stimulation is produced in intact cells
cAMP levels increase [35]. This suggests that when the cells are
lysed the components of the α1-adrenergic receptor pathway
separate and as they are not close there is no activation of adenylate
cyclase, so that cAMP concentration is not increased.
On the other hand, the increase of cAMP caused by α1-adrenergic
receptor represents about 70% of basal cAMP levels, whereas the stimu-
lation of adenylate cyclase with forskolin increases cAMP in 300–400%
[35]. This indicates that the effect of each receptor must be compart-
mentalized, i.e. Gαs protein, adenylate cyclase and PKA must be
preassembled and in close proximity to α1-adrenergic receptor. Thus,
as the α1-AR, Gαs protein, AC, PKA and Ito are preassembled, the 70%
increase in cAMP levels reduces Ito current amplitude because the
increase is restricted to the area surrounding the supramolecular com-
plex. However, broad increases in cAMP such as those caused by stimu-
lation of β-adrenergic receptor have no effect on Ito because the second
messenger is not increased in the “correct” place.
Moreover, when α1-AR activates adenylate cyclase, cAMP levels
increases only in speciﬁc subcellular domains and activates only a dis-
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because these targets are regulated by a different pool of PKAs.
The existence of distinct populations of PKAs localized near their
speciﬁc targets answers the previously raised questions about the abil-
ity of α1-AR stimulation to activate PKA without affecting i.e. L-type
calcium channels; and why β-adrenoceptors have no effect on Ito de-
spite they activate cAMP/PKA pathway.
4.4. α1-adrenoceptors regulate only the caveolae-located subpopulation
of cardiac Kv4 channels
It is one question remaining about the α1-AR-Gαs protein-AC-PKA
regulation of Ito: why does noradrenaline reduce Ito current only 35%
and why do not higher noradrenaline concentrations reduce Ito current
100%?
As explained in the previous section, in ventricular myocytes all the
components of theα1-AR/Ito signal transduction pathway that includes
the receptor, Gαs protein, AC, AKAP100, PKA, Kv4.2 and Kv4.3 are
raft-associated [72]. This preassembly within membrane domains al-
lows the quick regulation of the channel in response to α1-adrenergic
stimulation. Colchicine disrupts cytoskeleton structure and causes
caveolae removal from the membrane. When α1-adrenergic receptor
is stimulated in the presence of colchicine the amplitude of Ito is not
reduced because colchicine causes the molecules involved in the
α1-adrenergic receptor transduction pathway to separate, and as they
are not preassembled there is no effect on Ito [35].
Moreover, coimmunoprecipitation experiments and electron
micrographs [72] answer the question regardingα1-Adrenergic regu-
lation of Ito. As mentioned, maximum α1-AR stimulation reduces Ito
current amplitude up to a 35%. The presence of Kv4.3 channels out-
side caveolae demonstrates that two different Ito channel populations
exist. One, that is caveolae associated and sensitive to α1-adrenergic
regulation and a second channel population localized in non-caveolar
membrane rafts and α1-adrenergic independent (Fig. 5).
4.5. Genetic alterations in Caveolin and cardiac ionic channels
Considerable information exists in the literature about functional
cardiac abnormalities from caveolin-null mice or from caveolin muta-
tions identiﬁed in human patients. Caveolin KO or caveolin mutations
results in a phenotype of cardiac hypertrophy, characterized by an
increase in cardiomyocyte size and by interstitial ﬁbrosis, which
induces contractile dysfunction progressing to diastolic dysfunction
[89,90].
In human patients, mutations in caveolin-3 have been associated
with long QT syndrome (LQTS) and sudden infant dead syndrome
(SIDS). Most of the mutations reported to date affect the cardiac
excitability through the alteration in the function of cardiac Na
channels, which causes an increase in late sodium current [90–92].
As explained in the previous sections, caveolae contain numerous
signaling molecules such us β2- and α1-adrenoceptors, Gαs, Gαi and
Gαq proteins, MAPKs, Src kinases, etc, whichmodulates the expression
and function of many cardiac ionic channels. Thus, KO or mutations in
caveolin are also expected to produce alterations in the regulation of
cardiac ionic channels and, therefore, in the cardiac electrical activity.
The extent and the mechanisms involved is a ﬁeld waiting to be
explored.
5. Summary
Location of particular transduction components inside and outside
caveolae is an effective way of separating signaling pathways. In the
heart, the preassembly of the α1-AR-Kv4 transducing components
in caveolae ensures the fast reduction of Ito current triggered by sym-
pathetic stimulation when an increased contraction force is required.
However, the presence of another population of Kv4 channels locatedoutside caveolae and therefore not accessible to α1-AR mediated
regulation protects against the excessive reduction of the current, a
potentially arrhythmogenic situation.Acknowledgements
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